ADCT — Adc Therapeutics SA
On NYSE, Adc Therapeutics SA trades as ADCT.
Its activity is classified under HEALTHCARE, in the DRUG MANUFACTURERS - SPECIALTY & GENERIC industry.
Searching for the Adc Therapeutics SA share price, or whether to buy ADCT? This page brings together a live chart, momentum and risk scores, fresh news and community sentiment.
VAQO runs a statistical model over ADCT that reads seven technical indicators and translates them into an opportunity score and a risk score — including which factors drove them.
What ADCT is
ADC Therapeutics SA, a biotechnology company focused on clinical stage oncology, develops Antibody Drug Conjugates (ADC) for patients suffering from hematologic malignancies and solid tumors. The company is headquartered in Epalinges, Switzerland.…
Adc Therapeutics SA is classified under HEALTHCARE, in the DRUG MANUFACTURERS - SPECIALTY & GENERIC industry.
It trades on NYSE as a common stock.
ADCT size and valuation
At roughly $162.1M, ADCT is a micro-cap.
Earnings per share are negative at -0.62, so there is no meaningful price-to-earnings multiple to quote.
Beta is 1.86: historically it has moved more than the market.
ADCT over the past year
Over the past year ADCT has traded between $0.78 and $4.98, and the current price sits at 19% of that range.
The 50-day average is $1.14 against a 200-day average of $2.68 — the shorter average sits below the longer one, usually read as a downtrend.
The published analyst target is $3.33, 110.3% above it. A target is an aggregate of opinions, not a measurement.
How Adc Therapeutics SA (ADCT) is trading
Adc Therapeutics SA (ADCT) is down 3.35% at $1.59 — a more volatile session than average.
The session ranged from $1.52 to $1.64 — 7.9% of the share price — and the current price sits at 56% of that range.
It opened at $1.62 against a previous close of $1.64 — an opening gap of -1.5%, which almost always comes from information released outside trading hours.
The day's range extended past the previous close ($1.64) on both sides.
Volume ran near 823.0K shares, about $1.3M of stock changing hands.
Traded alongside ADCT
Names traded alongside ADCT in the same sector: A (Agilent Technologies Inc), AAPG (Ascentage Pharma Group International), AARD (Aardvark Therapeutics Inc), ABCL (AbCellera Biologics Inc), ABEO (Abeona Therapeutics Inc).
What VAQO's model says about ADCT
Two statistical models run over ADCT inside the browser, reporting momentum, risk and opportunity separately. Full accuracy for both, including when it falls, is published on the model page.
Key facts
- Symbol: ADCT
- Name: Adc Therapeutics SA
- Sector: HEALTHCARE
- Industry: DRUG MANUFACTURERS - SPECIALTY & GENERIC
- Exchange: NYSE
- Instrument: Stock
ADCT — frequently asked questions
What is the market cap of ADCT?
Adc Therapeutics SA has a market capitalisation of roughly $162.1M.
What is the 52-week range for ADCT?
ADCT has traded between $0.78 and $4.98 over the past year, with the current price at 19% of that range.
How much does ADCT stock cost today?
Adc Therapeutics SA (ADCT) trades at $1.59, a change of -3.35% in the latest session.
Is ADCT up or down today?
ADCT is down 3.35% in the latest session, at $1.59.
What is the daily trading range for ADCT?
ADCT traded between $1.52 and $1.64 in the latest session, and currently trades at $1.59.
What is the trading volume for ADCT?
ADCT traded roughly 823.0K shares in the latest session.
Which exchange is ADCT listed on?
ADCT is listed on NYSE, in the HEALTHCARE sector.
Should I buy ADCT stock?
VAQO gives no buy or sell recommendations and is not an investment adviser. The ADCT figures on this page — price, range, volume and the model's scores — are there to inform your decision, not to stand in for it.
Others in HEALTHCARE
- A — Agilent Technologies Inc
- AAPG — Ascentage Pharma Group International
- AARD — Aardvark Therapeutics Inc
- ABCL — AbCellera Biologics Inc
- ABEO — Abeona Therapeutics Inc
- ABOS — Acumen Pharmaceuticals Inc
Last updated: 2026-11-08